PubRank

Nicos Nicolaou

Author PubWeight™ 27.77‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Locoregional recurrence of triple-negative breast cancer after breast-conserving surgery and radiation. Cancer 2009 1.99
2 Randomized trial of amifostine in locally advanced non-small-cell lung cancer patients receiving chemotherapy and hyperfractionated radiation: radiation therapy oncology group trial 98-01. J Clin Oncol 2005 1.98
3 Increased recurrences using intensity-modulated radiation therapy in the postoperative setting. Am J Clin Oncol 2010 1.52
4 Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Protocol 9911. J Clin Oncol 2007 1.48
5 Intensity modulated radiation therapy (IMRT) decreases acute skin toxicity for women receiving radiation for breast cancer. Am J Clin Oncol 2006 1.45
6 Quality of life supersedes the classic prognosticators for long-term survival in locally advanced non-small-cell lung cancer: an analysis of RTOG 9801. J Clin Oncol 2009 1.34
7 Breast intensity-modulated radiation therapy reduces time spent with acute dermatitis for women of all breast sizes during radiation. Int J Radiat Oncol Biol Phys 2009 1.14
8 Pattern of local recurrence after conservative surgery and whole-breast irradiation. Int J Radiat Oncol Biol Phys 2005 1.08
9 Clinically meaningful differences in patient-reported outcomes with amifostine in combination with chemoradiation for locally advanced non-small-cell lung cancer: an analysis of RTOG 9801. Int J Radiat Oncol Biol Phys 2008 0.95
10 Intensity-modulated radiotherapy for early larynx cancer: is there a role? Int J Radiat Oncol Biol Phys 2007 0.95
11 Impact of neck dissection on long-term feeding tube dependence in patients with head and neck cancer treated with primary radiation or chemoradiation. Head Neck 2010 0.94
12 Routine mammography is associated with earlier stage disease and greater eligibility for breast conservation in breast carcinoma patients age 40 years and older. Cancer 2003 0.94
13 Cetuximab as primary treatment for cutaneous squamous cell carcinoma to the neck. Head Neck 2011 0.93
14 Toxicity and outcome analysis of patients with recurrent head and neck cancer treated with hyperfractionated split-course reirradiation and concurrent cisplatin and paclitaxel chemotherapy from two prospective phase I and II studies. Head Neck 2005 0.92
15 A phase II study of concurrent carboplatin and paclitaxel and thoracic radiotherapy for completely resected stage II and IIIA non-small cell lung cancer. J Thorac Oncol 2007 0.90
16 Postmastectomy chest wall radiation to a temporary tissue expander or permanent breast implant--is there a difference in complication rates? Int J Radiat Oncol Biol Phys 2008 0.90
17 Dermal lymphatic invasion and inflammatory breast cancer are independent predictors of outcome after postmastectomy radiation. Am J Clin Oncol 2009 0.88
18 Young age is not associated with increased local recurrence for DCIS treated by breast-conserving surgery and radiation. J Surg Oncol 2009 0.87
19 Contribution of flow cytometry in the diagnosis of cutaneous lymphoid lesions. J Invest Dermatol 2003 0.86
20 Parity confers better prognosis in older women with early-stage breast cancer treated with breast-conserving therapy. Clin Breast Cancer 2004 0.86
21 Genetics, the Big Five, and the tendency to be self-employed. J Appl Psychol 2010 0.84
22 Nonsurgical management of oropharyngeal, laryngeal, and hypopharyngeal cancer: the Fox Chase Cancer Center experience. Head Neck 2010 0.82
23 Impact of the radiation boost on outcomes after breast-conserving surgery and radiation. Int J Radiat Oncol Biol Phys 2010 0.79
24 Does mitosis-specific marker phosphohistone H3 help the grading of upper tract urothelial carcinomas in cell blocks? Acta Cytol 2012 0.78
25 Use of a conventional low neck field (LNF) and intensity-modulated radiotherapy (IMRT): no clinical detriment of IMRT to an anterior LNF during the treatment of head-and neck-cancer. Int J Radiat Oncol Biol Phys 2010 0.78
26 Health states of women after conservative surgery and radiation for breast cancer. Breast Cancer Res Treat 2009 0.77
27 Initial results of a Phase I dose-escalation trial of concurrent and maintenance erlotinib and reirradiation for recurrent and new primary head-and-neck cancer. Int J Radiat Oncol Biol Phys 2010 0.76
28 Phase I trial of concurrent hyperfractionated split course radiotherapy (HFx RT), cisplatin (cDDP), and paclitaxel in patients with recurrent, previously irradiated, or treatment-naïve locally advanced upper aerodigestive malignancy. Cancer Invest 2006 0.75